This study tests the safety and performance of a new pacemaker (Amvia) and a special lead (Solia CSP S) designed to pace the heart's natural electrical system more precisely. It involves 152 people who need a pacemaker or cardiac resynchronization therapy. Participants are follow…
Phase: NA • Sponsor: Biotronik SE & Co. KG • Aim: Disease control
Last updated May 01, 2026 16:01 UTC